TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia.
Khedmatgozar H, Dutta S, Dominguez M, Raju M, Patel GK, Latour D, Johnson MK, Fokar M, Warraich I, Haynes A Jr, Maurer BJ, de Riese W, Brandi L, Matusik RJ, Nandana S, Tripathi M.
Khedmatgozar H, et al. Among authors: haynes a jr.
JCI Insight. 2025 May 20;10(12):e188062. doi: 10.1172/jci.insight.188062. eCollection 2025 Jun 23.
JCI Insight. 2025.
PMID: 40392613
Free PMC article.